GlobeNewswire
-
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
03/03/2026 -
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/03/2026 -
Vaxart to Host Upcoming Conference Calls
03/03/2026 -
TimelyCare Honored as Virtual Student Health and Wellness Services Company of the Year 2026 by Education Insider
03/03/2026 -
Testosterone Booster Supplement for Men Over 50 — TestoPrime Medically Accredited by Clinicians' Choice in 2026
03/03/2026 -
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
03/03/2026 -
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
03/03/2026 -
Sympathiq Launches Well-Being Marketplace Connecting UK Residents with Certified Mental Health Specialists
03/03/2026 -
2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline
03/03/2026 -
Résultats 2025 : amélioration de la marge de Core EBITDA en dépit de vents contraires sur l’activité, grâce à une stricte discipline financière
03/03/2026 -
Suzanne Nora Johnson Joins Wellcome Leap Board of Directors
03/03/2026 -
Spryte Medical Announces First Participants Enrolled in the INSYTE Trial at Baptist Health Jacksonville
03/03/2026 -
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing
03/03/2026 -
Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of a Definitive Agreement
03/03/2026 -
Journal of Analytical Toxicology Publishes Peer-Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories’ Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies’ Breath Collection Unit
03/03/2026 -
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
03/03/2026 -
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
03/03/2026 -
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
03/03/2026 -
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
03/03/2026
Pages